In vitro and in vive binding of a CC-1065 analogue to human gene sequences: A polymerase-chain reaction study

European Journal of Pharmacology

Volumn 319, Issue 2-3, 1997, Pages 317-325

  Passadore, Marco ^a   Bianchi, Nicoletta ^a   Feriotto, Giordana ^a   Mischiati, Carlo ^a   Rutigliano, Cristina ^a   Gambari, Roberto ^a  

^a UNIVERSITY OF FERRARA   (Italy)

Author keywords

CC 1065 analog; Gene sequence, human; PCR (polymerase chain reaction

Indexed keywords

ESTROGEN RECEPTOR; U 71184; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIBIOTIC; DISTAMYCIN A; DNA; INDOLE DERIVATIVE; KITASAMYCIN DERIVATIVE; RACHELMYCIN;

ARTICLE; CELL STRAIN MCF 7; CONTROLLED STUDY; GENE SEQUENCE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; BREAST TUMOR; CELL CULTURE; FRAGILE X SYNDROME; GENETICS; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; ONCOGENE RAS;

ANTI-BACTERIAL AGENTS; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; BASE SEQUENCE; BREAST NEOPLASMS; CELLS, CULTURED; DISTAMYCINS; DNA; FRAGILE X SYNDROME; GENES, RAS; HUMANS; INDOLES; LEUCOMYCINS; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; RECEPTORS, ESTROGEN;

EID: 0030614710     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(96)00849-7     Document Type: Article

References (42)

1. Aristoff, P.A., 1993, CC-1065 analogs: sequence specific DNA alkylating antitumor agents, Adv. Med. Chem. 2, 67.
2. Berg, O.G. and P.H. Von Hippel, 1988, Selection of DNA binding sites by regulatory proteins, Trends Biochem. Sci. 13, 207.
3. Broggini, M., M. Ponti, S. Ottolenghi, M. D'Incalci, N. Mongelli and R. Mantovani, 1989, Distamycins inhibit the binding of OTF-1 and NFE-1 transfactors to their conserved DNA elements, Nucleic Acids Res. 17, 1051.
4. Chiang, S., Y. Welch, F.J. Rauscher III and T.A. Beerman, 1994, Effects of minor groove binding drugs on the interactions of TATA box binding protein and TFIIA with DNA, Biochemistry 33, 7033.
5. Churchill, M.E.A., J.J. Hayes and T.D. Tullius, 1990, Detection of drug binding to DNA by hydroxyl radical footprinting. Relationship of distamycin binding sites to DNA structure and positioned nucleosomes of 5S RNA genes of Xenopus, Biochemistry 29, 6043.
6. Del Senno, L., G.L. Aguiari and R. Piva, 1992, Dinucleotide repeat polymorphism in the human estrogen receptor (ER) gene, Hum. Mol. Genet. 1, 354.
7. Dervan, P.B., 1986, Design of sequence-specific DNA binding molecules, Science 232, 464.
8. Dorn, A., M. Affolter, M. Muller, W.J. Gehring and W. Leupin, 1992, Distamycin-induced inhibition of homeodomain-DNA complexes, EMBO J. 11, 279.
9. Erster, S.H., W.T. Brown, P. Goonewardena, C.S. Dobkin, E.C. Jenkins and R.G. Pergolizzi, 1992, Polymerase-chain reaction analysis of fragile X mutations, Hum. Gen. 80, 55.
10. Faisst, S. and S. Meyer, 1992, Compilation of vertebrate-encoded transcription factors, Nucleic Acids Res. 20, 3.
11. Feriotto, G., C. Mischiati and R. Gambari, 1994a, Sequence-specific recognition of the HIV-1 long terminal repeat by distamycin: a DNase I footprinting study, Biochem. J. 299, 451.
12. Feriotto, G., A. Ciucci, C. Mischiati F. Animati, P. Lombardi, P. Giacomini, F. Arcamone and R. Gambari, 1994b, Binding of Epstein-Barr virus nuclear antigen 1 to DNA: inhibition by distamycin and two novel distamycin analogues, Eur. J. Pharmacol. 267, 143.
13. Feriotto, G., C. Mischiati, N. Bianchi, M. Passadore and R. Gambari, 1995, Binding of distamycin and chromomycin to human immunodeficiency type 1 virus DNA: a non-radioactive automated footprinting study, Eur. J. Pharmacol. 290, 85.
14. Fox, K.R., C.E. Sansom and M.F.G. Stevens, 1990, Footprinting studies on the sequence-selective binding of pentamidine to DNA, FEBS Lett. 266, 150.
15. Gambari, R. and C. Nastruzzi, 1994, DNA-binding activity and biological effects of aromatic polyamidines, Biochem. Pharmacol. 47, 599.
16. Gambari, R., R. Barbieri, C. Nastruzzi, V. Chiorboli, G. Feriotto, P.G. Natali, P. Giacomini and F. Arcamone, 1991, Distamycin inhibits the binding of a nuclear factor to the -278/-256 upstream sequence of the human HLA-DRα gene, Biochem. Pharmacol. 41, 495.
17. Gao, X. and D.J. Patel, 1989, Solution structure of the chromomycin-DNA complex, Biochemistry 28, 751.
18. Gaynor, G., 1992, Cellular transcription factors involved in the regulation of HIV-1 gene expression, AIDS 6, 347.
19. Green, S., P. Walter, V. Kumar, A. Krust, J.M. Bornert, P. Argos and P. Chambon, 1986, Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A, Nature 320, 134.
20. Hurley, L.H., C. Lee, J.P. McGovren, M.A. Warpehosky, M.A. Mitchell, R.C. Kelly and P.A. Aristoff, 1988, Molecular basis for sequence-specific DNA alkylation by CC-1065, Biochemistry 27, 3886.
21. Hurley, L.H., M.A. Warpehoski, C-S. Lee, J.P. McGovren, T.A. Scahill, R.C. Kelly, M.A. Mitchell, N.A. Wicnienski, I. Geebhard, P.D. Johnson and V.S. Bradford, 1990, Sequence specificity of DNA alkylation by the unnatural enantiomer of CC-1065 and its synthetic analogues, J. Am. Chem. Soc. 112, 4633.
22. Laughton, C.A., T.C. Jenkins, K.R. Fox and S. Neidle, 1990, Interaction of berenil with the tyrT DNA sequence studied by footprinting and molecular modelling. Implications for the design of sequence-specific DNA recognition agents, Nucleic Acids Res. 18, 4479.
23. Lewin, B., 1991, Oncogenic conversion by regulatory changes in transcription factors, Cell 64, 303.
24. Lown, J.W., 1988, Lexitropsins: rationale design of DNA sequence reading agents as novel anticancer agents and potential cellular probes, Anti-Cancer Drug Design 3, 25.
25. Mitchell, P.J. and R. Tjian, 1989, Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins, Science 245, 371.
26. Mohamadi, F., M.M. Spees, G.S. Staten, P. Marder, J.K. Kipka and D.A. Johnson, 1994, Total synthesis and biological properties of novel antineoplastic (chloromethyl)furanoindolines: an asymmetric hydroboration mediated synthesis of the alkylation subunits, J. Med. Chem. 37, 232.
27. Passadore, M., G. Feriotto, N. Bianchi, G.L. Aguiari, C. Mischiati, R. Piva and R. Gambari, 1994, Polymerase-chain reaction as a tool for investigations on sequence-selectivity of DNA-drugs interactions, J. Biochem. Biophys. Methods 29, 307.
28. Passadore, M., N. Bianchi, G. Feriotto, C. Mischiati, P. Giacomini, R. Piva and R. Gambari, 1995, Differential effects of distamycin analogues on amplification of human gene sequences by polymerase-chain reaction, Biochem. J. 308, 513.
29. Piva, R. and L. Del Senno, 1993, Analysis of a DNA sequence upstream of the human estrogen receptor gene, Ann. NY Acad. Sci. 68, 235.
30. Piva, R., R. Gambari, F. Zorzato, L. Kumar and L. Del Senno, 1992, Analysis of upstream sequences of the human estrogen receptor gene, Biochem. Biophys. Res. Commun. 183, 996.
31. Piva, R., N. Bianchi, G.L. Aguiari, R. Gambari and L. Del Senno, 1993, Sequencing of an RNA transcript of the human estrogen receptor gene: evidence for a new transcriptional event, J. Steroid Biochem. Mol. Biol. 46, 531.
32. Portugal, J. and M.J. Waring, 1987, Hydroxy radical footprinting of the sequence-selective binding of netropsin and distamycin to DNA, FEBS Lett. 225, 195.
33. Ray, R., R.C. Snyder, S. Thomas, C.A. Koller and D.M. Miller, 1989, Mithramycin blocks protein binding and function of the SV40 early promoter, J. Clin. Invest. 83, 2003.
34. Saiki, R.K., D.H. Gelfand, S. Stoffel, S.J. Scharf, R. Higuchi, G.T. Horn, K.B. Mullis and H.A. Erlich, 1988, Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase, Science 239, 487.
35. Santos, E., S.R. Tronick, S.A. Aaranson, S. Pulciani and M. Barbacid, 1982, T24 human bladder carcinoma oncogene is an activated form of the normal human homologue of BALB- and Harvey-MSV transforming genes, Nature 298, 343.
36. Snyder, R.C., R. Ray, S. Blume and D.M. Miller, 1991, Mithramycin blocks transcriptional initiation of the c-myc P1 and P2 promoters, Biochemistry 30, 4290.
37. Spandidos, D.A. and N.M. Wilkie, 1984, Malignant transformation of early passage rodent cells by a single mutated human oncogene, Nature 310, 469.
38. Van Dyke, W.W. and P.B. Dervan, 1983, Chromomycin, mithramycin and olivomycin binding sites on heterogeneous deoxyribonucleic acid. Footprinting with (methidiumpropyl-EDTA)iron(II), Biochemistry 22, 2373.
39. Warpehoski, M.A., 1986, Total synthesis of U-71184. A potent new antitumor agent modeled on CC-1065, Tetrahedron Lett. 27, 4103.
40. Warpehoski, M.A., D.E. Harper, M.A. Mitchell and T.J. Monroe, 1992, Reversibility of the covalent reaction of CC-1065 and analogues with DNA, Biochemistry 31, 2502.
41. Welch, J.J., F.J. Rausher III and T.A. Beerman, 1994, Targeting DNA-binding drugs to sequence-specific transcription factor DNA complexes, J. Biol. Chem. 269, 31051.
42. White, R.J. and D.R. Phillips, 1989, Bidirectional transcription footprinting of DNA binding ligands, Biochemistry 28, 6259.